| Concomitant |
| Constipation |
16.1% |
| Product Used For Unknown Indication |
14.0% |
| Drug Use For Unknown Indication |
12.5% |
| Pain |
9.7% |
| Epilepsy |
6.4% |
| Hypertension |
5.8% |
| Prophylaxis |
5.8% |
| Schizophrenia, Paranoid Type |
3.6% |
| Breast Cancer |
3.3% |
| Thrombosis Prophylaxis |
2.7% |
| Back Pain |
2.4% |
| Depression |
2.4% |
| Nausea |
2.4% |
| Abnormal Behaviour |
2.1% |
| Anaesthesia |
1.8% |
| Epstein-barr Virus Infection |
1.8% |
| Mantle Cell Lymphoma |
1.8% |
| Multiple Myeloma |
1.8% |
| Vertigo |
1.8% |
| Anaemia |
1.5% |
|
| Electrocardiogram Qt Prolonged |
11.5% |
| Pulmonary Embolism |
8.2% |
| Malaise |
6.6% |
| Proctitis |
6.6% |
| Renal Failure Acute |
6.6% |
| Hyponatraemia |
4.9% |
| Pancreatitis |
4.9% |
| T-cell Lymphoma |
4.9% |
| Tachycardia |
4.9% |
| Vomiting |
4.9% |
| Weight Decreased |
4.9% |
| Wound Debridement |
4.9% |
| Bone Marrow Failure |
3.3% |
| Confusional State |
3.3% |
| Convulsion |
3.3% |
| Dehydration |
3.3% |
| Febrile Bone Marrow Aplasia |
3.3% |
| Hepatic Function Abnormal |
3.3% |
| Hypoalbuminaemia |
3.3% |
| International Normalised Ratio Increased |
3.3% |
|
